Close Menu

NEW YORK (360Dx) – Deep Lens said today that it has closed a $14 million Series A round to further expand its artificial intelligence and platform product development activities. It will also use the financing to scale its service, sales, and marketing organizations to support demand and growth for its approach to clinical trial recruitment.

The Series A closing comes three months after Columbus, Ohio-based Deep Lens completed a venture capital-led seed equity round, bringing its funding to date to $17.5 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.